Lataa...
Cancer vaccines: Steering T cells down the right path to eradicate tumors
Lack of tumor T-cell infiltration is a barrier to the efficacy of immune checkpoint inhibitors and other immunotherapies in cancer patients. Because of their ability to activate and augment tumor-specific T cells, vaccines are an attractive approach to direct T cell responses into the tumor.
Tallennettuna:
| Julkaisussa: | Cancer Discov |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7067230/ https://ncbi.nlm.nih.gov/pubmed/30862723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-18-1357 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|